Table of Content

1. Executive Summary
   1. Africa Pharmaceuticals Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Europe Sectoral Outlook
      2. Europe GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Distribution Channel Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Prices, By Therapeutic Area
   3. Pricing Analysis, By Therapeutic Area
   4. Regional Prices and Therapeutic Area Preferences
5. Africa Pharmaceuticals Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Africa Pharmaceuticals Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Therapeutic Area, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
         1. Oncology
         2. Infectious Diseases & Vaccines
         3. Diabetes
         4. Cardiovascular
         5. Anti-Rheumatic & Immunology
         6. Others
      4. Market Attractiveness Analysis: Therapeutic Area
   4. Africa Pharmaceuticals Market Outlook: Drug Classification
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Classification, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Drug Classification, 2025 - 2032
         1. Branded/Innovator Drugs
         2. Generic Drugs
         3. Branded Generics
         4. Biologics & Biosimilars
      4. Market Attractiveness Analysis: Drug Classification
   5. Africa Pharmaceuticals Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Direct Tenders/Public Sector Procurement
         2. Retail/Community Pharmacies
         3. Hospitals/Healthcare Facilities
         4. E-Commerce/Online Pharmacies
         5. Private Sector Healthcare Networks
      4. Market Attractiveness Analysis: Distribution Channel
6. Africa Pharmaceuticals Market Outlook: Country
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Country, 2019 - 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Country, 2025 - 2032
      1. South Africa
      2. Egypt
      3. Nigeria
      4. Rest of Africa
   4. Market Attractiveness Analysis: Country
7. Competition Landscape
   1. Market Share Analysis, 2024
   2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
   3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Aspen Pharmacare Holdings Limited
         1. Overview
         2. Segments and Therapeutic Areas
         3. Key Financials
         4. Market Developments
         5. Market Strategy
      2. EIPICO
      3. CIPLA South Africa
      4. Adcock Ingram Holdings Limited
      5. May & Baker Nigeria PLC
      6. UAC Pharma
      7. Pharco Pharmaceuticals
      8. EMZOR Pharmaceuticals Industries Limited
      9. Alexandria Pharmaceuticals
      10. Biopure Group
      11. Medtech Innovators
      12. GlaxoSmithKline South Africa
      13. Novartis Pharma South Africa
      14. Roche South Africa
      15. Johnson & Johnson South Africa Medical
8. Appendix
   1. Research Methodology
   2. Research Assumptions
   3. Acronyms and Abbreviations